Results 161 to 170 of about 427,417 (300)

Provably Secure Authenticated Tree Based Group Key Agreement Protocol

, 2004
We present a provably secure authenticated tree based key agreement protocol. The protocol is obtained by combining Boldyreva\u27s multi-signature with an unauthenticated ternary tree based multi-party extension of Joux\u27s key agreement protocol.
Palash Sarkar, Ratna Dutta, Rana Barua
core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

Molecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain, Yann Le Page, Frédéric Percevault, Emmanuelle Becker, Luc Negroni, Almudena Fernandez, Marta Cantero, Diego Muñoz‐Santos, Lluís Montoliu, Cyrille Garnier, Michael Primig   +10 more
wiley   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source

A Lightweight Hybrid Authentication and Key Agreement Protocol for Decentralized Device-to-Device Communication with Post-Quantum Confidentiality. [PDF]

Sensors (Basel)
Savón-Berenguer A, Moraru SA, García-Naranjo JC, Braeken A.   +3 more
europepmc   +1 more source

Weakness in Simple Authenticated Key Agreement Protocol

, 2012
[[abstract]]Seo and Sweeney recently proposed a simple authenticated key agreement protocol using a password-based method [see ibid., vol. 35, no. 13, p. 1073, 1999].
Tseng, Yuh-Min
core  

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

Molecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak, Iva Staniczková Zambo, Matěj Přikryl, Peter Múdry, Danica Zapletalová, Jarmila Navrátilová, Jiří Navrátil, Jan Šmarda, Liudmyla Drobot, Petr Beneš, Lucia Knopfová   +10 more
wiley   +1 more source

A Post-Quantum Authentication and Key Agreement Protocol Based on Lattice-Based KEM for Secure Network Environments. [PDF]

Entropy (Basel)
Chen X, Wu W, Liang G, Tan H, Yu Y.
europepmc   +1 more source

An improved authenticated key agreement protocol for telecare medicine information system. [PDF]

Springerplus, 2016
Liu W, Xie Q, Wang S, Hu B.
europepmc   +1 more source

On-line Password Guessing Attack on Lu-Cao Key Agreement Protocol for Secure Authentication

, 2010
[[abstract]]In 2006, Lu and Cao proposed an off-line password guessing attack on an efficient key agreement protocol for secure authentication. Lu and Cao pointed out that the Kim et al.’s protocol is vulnerable to the off-line password guessing attack ...
Cheng-Chi Lee; Kou-You Huang; Shiow-Yuan Huang
core  

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source